MeiraGTx (MGTX) Stock Forecast, Price Target & Predictions

OverviewRevenue Ownership Financials Chart

MGTX Stock Forecast

MeiraGTx stock forecast is as follows: an average price target of $9.00 (represents a 38.89% upside from MGTX’s last price of $6.48) and a rating consensus of 'Buy', based on 2 wall street analysts offering a 1-year stock forecast.

MGTX Price Target

The average price target for MeiraGTx (MGTX) is $9.00 based on 1-year price targets from 2 Wall Street analysts in the past 3 months, with a price target range of $9.00 to $9.00. This represents a potential 38.89% upside from MGTX's last price of $6.48.

MGTX Analyst Ratings

Buy

According to 2 Wall Street analysts, MeiraGTx's rating consensus is 'Buy'. The analyst rating breakdown for MGTX stock is 0 'Strong Buy' (0.00%), 2 'Buy' (100.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

MeiraGTx Price Target by Analyst

Date	Analyst	Company	Price Target	Price when Published	Price Target/Price when Published	Price Target/Last Closing Price
Aug 13, 2024	Luca Issi	RBC Capital	$9.00	$4.02	123.88%	38.89%

Row per page

Go to

The latest MeiraGTx stock forecast, released on Aug 13, 2024 by Luca Issi from RBC Capital, set a price target of $9.00, which represents a 123.88% increase from the stock price at the time of the forecast ($4.02), and a 38.89% increase from MGTX last price ($6.48).

MeiraGTx Price Target by Period

	1M	3M	12M
# Anlaysts	-	-	1
Avg Price Target	-	-	$9.00
Last Closing Price	$6.48	$6.48	$6.48
Upside/Downside	-100.00%	-100.00%	38.89%

In the current month, the average price target of MeiraGTx stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to MeiraGTx's last price of $6.48. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.

Analyst Ratings Upgrades/Downgrades

Date	Company	Previous Rating	New Rating	Rating Change
Oct 11, 2024	Piper Sandler	Overweight	Overweight	Hold
Aug 13, 2024	RBC Capital	Outperform	Outperform	Hold

Row per page

Go to

MeiraGTx's last stock rating was published by Piper Sandler on Oct 11, 2024. The company gave MGTX a "Overweight" rating, the same as its previous rate.

MeiraGTx Financial Forecast

MeiraGTx Revenue Forecast

	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Mar 20	Sep 19	Jun 19	Mar 19
Revenue	-	-	-	-	-	-	-	-	$2.04M	$5.10M	-	$3.33M	$-5.29M	$4.82M	$10.76M	$5.63M	$4.38M	$6.95M	$5.12M	$4.59M	$3.79M	$5.09M	$4.21M	$3.58M	$1.98M	$784.96K
Avg Forecast	$167.50M	$1.50M	$1.50M	$1.50M	$1.10M	$1.20M	$9.70M	$9.70M	$6.56M	$3.27M	$4.17M	$4.87M	$10.90M	$6.99M	$5.82M	$4.08M	$2.40M	$2.25M	$1.43M	$5.68M	$907.02K	$2.70M	$700.00K	$863.46K	$2.50K	$810.28K
High Forecast	$167.50M	$1.50M	$1.50M	$1.50M	$1.10M	$1.20M	$9.70M	$9.70M	$6.56M	$3.27M	$4.17M	$4.87M	$10.90M	$6.99M	$5.82M	$4.08M	$2.40M	$2.25M	$1.43M	$5.68M	$907.02K	$2.70M	$700.00K	$863.46K	$2.50K	$972.34K
Low Forecast	$167.50M	$1.50M	$1.50M	$1.50M	$1.10M	$1.20M	$9.70M	$9.70M	$6.56M	$3.27M	$4.17M	$4.87M	$10.90M	$6.99M	$5.82M	$4.08M	$2.40M	$2.25M	$1.43M	$5.68M	$907.02K	$2.70M	$700.00K	$863.46K	$2.50K	$648.22K
# Analysts	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	9	9	9	9	9	8	8	10
Surprise %	-	-	-	-	-	-	-	-	0.31%	1.56%	-	0.69%	-0.49%	0.69%	1.85%	1.38%	1.83%	3.09%	3.57%	0.81%	4.18%	1.89%	6.01%	4.15%	792.67%	0.97%

MeiraGTx's average Quarter revenue forecast for Mar 24 based on 1 analysts is $9.70M, with a low forecast of $9.70M, and a high forecast of $9.70M. MGTX's average Quarter revenue forecast represents a 375.49% increase compared to the company's last Quarter revenue of $2.04M (Dec 23).

MeiraGTx EBITDA Forecast

	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Mar 20	Sep 19	Jun 19	Mar 19
# Analysts	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	9	9	9	9	9	8	8	10
EBITDA	-	-	-	-	-	-	-	-	$-43.75M	$-28.76M	$-28.79M	$-31.16M	$-37.77M	$-20.49M	$-21.63M	$-26.60M	$-10.37M	$-23.85M	$-18.02M	$-21.80M	$1.38M	$-5.33M	$-14.83M	$-10.26M	$-20.37M	$-17.47M
Avg Forecast	$-167.50M	$-1.50M	$-1.50M	$-1.50M	$-1.10M	$-1.20M	$-9.70M	$-9.70M	$-6.56M	$-3.27M	$-4.17M	$-4.87M	$-10.90M	$-6.99M	$-5.82M	$-18.86M	$-2.40M	$-2.25M	$-1.43M	$-15.57M	$-907.02K	$-2.70M	$-16.38M	$-863.46K	$-2.50K	$-18.02M
High Forecast	$-167.50M	$-1.50M	$-1.50M	$-1.50M	$-1.10M	$-1.20M	$-9.70M	$-9.70M	$-6.56M	$-3.27M	$-4.17M	$-4.87M	$-10.90M	$-6.99M	$-5.82M	$-15.09M	$-2.40M	$-2.25M	$-1.43M	$-12.46M	$-907.02K	$-2.70M	$-13.10M	$-863.46K	$-2.50K	$-14.41M
Low Forecast	$-167.50M	$-1.50M	$-1.50M	$-1.50M	$-1.10M	$-1.20M	$-9.70M	$-9.70M	$-6.56M	$-3.27M	$-4.17M	$-4.87M	$-10.90M	$-6.99M	$-5.82M	$-22.64M	$-2.40M	$-2.25M	$-1.43M	$-18.69M	$-907.02K	$-2.70M	$-19.65M	$-863.46K	$-2.50K	$-21.62M
Surprise %	-	-	-	-	-	-	-	-	6.67%	8.80%	6.91%	6.41%	3.46%	2.93%	3.72%	1.41%	4.32%	10.60%	12.57%	1.40%	-1.52%	1.97%	0.91%	11.88%	8147.08%	0.97%

9 analysts predict MGTX's average Quarter EBITDA for Mar 21 to be $-15.57M, with a high of $-12.46M and a low of $-18.69M. This is -1231.35% lower than MeiraGTx's previous annual EBITDA (Dec 20) of $1.38M.

MeiraGTx Net Income Forecast

	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Mar 20	Sep 19	Jun 19	Mar 19
# Analysts	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	9	9	9	9	9	8	8	10
Net Income	-	-	-	-	-	-	-	-	$20.21M	$-44.30M	$-29.58M	$-32.03M	$-13.57M	$-51.76M	$-44.19M	$-33.36M	$-12.16M	$-25.95M	$-20.09M	$-23.62M	$-10.46K	$-6.43M	$-15.68M	$-10.46M	$-20.82M	$-17.98M
Avg Forecast	$71.99M	$10.03M	$6.09M	$6.45M	$-37.97M	$-40.35M	$-28.65M	$-36.17M	$1.79M	$-39.16M	$-39.22M	$-47.04M	$-41.67M	$-41.20M	$-41.20M	$-20.30M	$-32.57M	$-34.63M	$-25.75M	$-16.87M	$-44.81M	$-29.61M	$-17.31M	$-10.30M	$-41.20M	$-18.54M
High Forecast	$71.99M	$10.03M	$6.09M	$6.45M	$-37.97M	$-40.35M	$-28.65M	$-36.17M	$1.79M	$-39.16M	$-39.22M	$-47.04M	$-41.67M	$-41.20M	$-41.20M	$-16.24M	$-32.57M	$-34.63M	$-25.75M	$-13.50M	$-44.81M	$-29.61M	$-13.85M	$-10.30M	$-41.20M	$-14.84M
Low Forecast	$71.99M	$10.03M	$6.09M	$6.45M	$-37.97M	$-40.35M	$-28.65M	$-36.17M	$1.79M	$-39.16M	$-39.22M	$-47.04M	$-41.67M	$-41.20M	$-41.20M	$-24.36M	$-32.57M	$-34.63M	$-25.75M	$-20.24M	$-44.81M	$-29.61M	$-20.78M	$-10.30M	$-41.20M	$-22.25M
Surprise %	-	-	-	-	-	-	-	-	11.29%	1.13%	0.75%	0.68%	0.33%	1.26%	1.07%	1.64%	0.37%	0.75%	0.78%	1.40%	0.00%	0.22%	0.91%	1.02%	0.51%	0.97%

MeiraGTx's average Quarter net income forecast for Mar 24 is $-36.17M, with a range of $-36.17M to $-36.17M. MGTX's average Quarter net income forecast represents a -278.95% decrease compared to the company's last Quarter net income of $20.21M (Dec 23).

MeiraGTx SG&A Forecast

	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Mar 20	Sep 19	Jun 19	Mar 19
# Analysts	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	9	9	9	9	9	8	8	10
SG&A	-	-	-	-	-	-	-	-	$12.12M	$10.01M	$12.39M	$12.77M	$14.00M	$10.76M	$10.52M	$11.27M	$15.55M	$7.89M	$10.41M	$9.92M	$12.01M	$8.90M	$11.81M	$9.87M	$13.44M	$8.50M
Avg Forecast	$462.69M	$4.14M	$4.14M	$4.14M	$3.04M	$3.31M	$26.79M	$26.79M	$18.13M	$9.03M	$11.51M	$13.44M	$30.12M	$17.98M	$14.95M	$10.49M	$6.17M	$5.78M	$3.68M	$14.59M	$2.33M	$6.94M	$1.80M	$2.22M	$6.43K	$2.08M
High Forecast	$462.69M	$4.14M	$4.14M	$4.14M	$3.04M	$3.31M	$26.79M	$26.79M	$18.13M	$9.03M	$11.51M	$13.44M	$30.12M	$17.98M	$14.95M	$10.49M	$6.17M	$5.78M	$3.68M	$14.59M	$2.33M	$6.94M	$1.80M	$2.22M	$6.43K	$2.50M
Low Forecast	$462.69M	$4.14M	$4.14M	$4.14M	$3.04M	$3.31M	$26.79M	$26.79M	$18.13M	$9.03M	$11.51M	$13.44M	$30.12M	$17.98M	$14.95M	$10.49M	$6.17M	$5.78M	$3.68M	$14.59M	$2.33M	$6.94M	$1.80M	$2.22M	$6.43K	$1.67M
Surprise %	-	-	-	-	-	-	-	-	0.67%	1.11%	1.08%	0.95%	0.46%	0.60%	0.70%	1.07%	2.52%	1.36%	2.82%	0.68%	5.15%	1.28%	6.56%	4.45%	2091.06%	4.08%

MeiraGTx's average Quarter SG&A projection for Mar 24 is $26.79M, based on 1 Wall Street analysts, with a range of $26.79M to $26.79M. The forecast indicates a 121.00% rise compared to MGTX last annual SG&A of $12.12M (Dec 23).

MeiraGTx EPS Forecast

	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Mar 20	Sep 19	Jun 19	Mar 19
# Analysts	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	9	9	9	9	9	8	8	10
EPS	-	-	-	-	-	-	-	-	$0.42	$-0.74	$-0.00	$-0.66	$-0.31	$-1.16	$-0.99	$-0.75	$-0.28	$-0.59	$-0.46	$-0.54	$-0.00	$-0.17	$-0.43	$-0.30	$-0.63	$-0.62
Avg Forecast	$1.00	$0.14	$0.09	$0.09	$-0.53	$-0.56	$-0.40	$-0.51	$0.03	$-0.55	$-0.55	$-0.66	$-0.58	$-0.64	$-0.64	$-0.49	$-0.51	$-0.54	$-0.40	$-0.30	$-0.70	$-0.46	$-0.52	$-0.16	$-0.64	$-0.66
High Forecast	$1.00	$0.14	$0.09	$0.09	$-0.53	$-0.56	$-0.40	$-0.51	$0.03	$-0.55	$-0.55	$-0.66	$-0.58	$-0.64	$-0.64	$-0.49	$-0.51	$-0.54	$-0.40	$-0.30	$-0.70	$-0.46	$-0.52	$-0.16	$-0.64	$-0.53
Low Forecast	$1.00	$0.14	$0.09	$0.09	$-0.53	$-0.56	$-0.40	$-0.51	$0.03	$-0.55	$-0.55	$-0.66	$-0.58	$-0.64	$-0.64	$-0.49	$-0.51	$-0.54	$-0.40	$-0.30	$-0.70	$-0.46	$-0.52	$-0.16	$-0.64	$-0.79
Surprise %	-	-	-	-	-	-	-	-	16.80%	1.35%	0.00%	1.01%	0.53%	1.81%	1.55%	1.52%	0.55%	1.10%	1.15%	1.82%	0.00%	0.37%	0.83%	1.88%	0.98%	0.94%

According to 1 Wall Street analysts, MeiraGTx's projected average Quarter EPS for Mar 24 is $-0.51, with a low estimate of $-0.51 and a high estimate of $-0.51. This represents a -220.24% decrease compared to MGTX previous annual EPS of $0.42 (Dec 23).

MeiraGTx Peer Comparison by Price Target

Ticker	Company	Last Closing Price	Avg Price Target	Upside/Downside	Avg Rating
QURE	uniQure	$6.21	$53.67	764.25%	Buy
SLDB	Solid Biosciences	$4.85	$17.50	260.82%	Buy
RCKT	Rocket Pharmaceuticals	$13.98	$45.20	223.32%	Buy
CCCC	C4 Therapeutics	$4.31	$13.50	213.23%	Buy
ABOS	Acumen Pharmaceuticals	$2.40	$7.00	191.67%	Buy
FIXX	Q32 Bio	$0.93	$2.70	190.32%	Buy
ANAB	AnaptysBio	$19.00	$52.00	173.68%	Buy
ERAS	Erasca	$2.67	$7.00	162.17%	Buy
NUVB	Nuvation Bio	$2.63	$6.75	156.65%	Buy
KRON	Kronos Bio	$0.85	$1.63	91.76%	Buy
KROS	Keros Therapeutics	$56.62	$102.60	81.21%	Buy
IDYA	IDEAYA Biosciences	$26.64	$46.58	74.85%	Buy
EWTX	Edgewise Therapeutics	$31.44	$45.00	43.13%	Buy
MGTX	MeiraGTx	$6.48	$9.00	38.89%	Buy
CNTB	Connect Biopharma	$1.11	$1.50	35.14%	Buy
ETON	Eton Pharmaceuticals	$10.02	$13.00	29.74%	Buy
RYTM	Rhythm Pharmaceuticals	$56.23	$55.20	-1.83%	Buy

MGTX Forecast FAQ

Is MeiraGTx a good buy?

Yes, according to 2 Wall Street analysts, MeiraGTx (MGTX) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 2 'Buy' recommendations, accounting for 100.00% of MGTX's total ratings.

What is MGTX's price target?

MeiraGTx (MGTX) average price target is $9 with a range of $9 to $9, implying a 38.89% from its last price of $6.48. The data is based on 2 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will MeiraGTx stock go up soon?

According to Wall Street analysts' prediction for MGTX stock, the company can go up by 38.89% (from the last price of $6.48 to the average price target of $9), up by 38.89% based on the highest stock price target, and up by 38.89% based on the lowest stock price target.

Can MeiraGTx stock reach $10?

MGTX's average twelve months analyst stock price target of $9 does not support the claim that MeiraGTx can reach $10 in the near future.

What are MeiraGTx's analysts' financial forecasts?

MeiraGTx's analysts financial forecasts for the fiscal year (Dec 2024) are as follows: average revenue is $21.7M (high $21.7M, low $21.7M), average EBITDA is $-21.7M (high $-21.7M, low $-21.7M), average net income is $-143M (high $-143M, low $-143M), average SG&A $59.94M (high $59.94M, low $59.94M), and average EPS is $-1.998 (high $-1.998, low $-1.998). MGTX's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $172M (high $172M, low $172M), average EBITDA is $-172M (high $-172M, low $-172M), average net income is $94.56M (high $94.56M, low $94.56M), average SG&A $475.12M (high $475.12M, low $475.12M), and average EPS is $1.32 (high $1.32, low $1.32).

Did the MGTX's actual financial results beat the analysts' financial forecasts?

Based on MeiraGTx's last annual report (Dec 2022), the company's revenue was $15.92M, which missed the average analysts forecast of $27.8M by -42.73%. Apple's EBITDA was $-116M, beating the average prediction of $-42.577M by 171.45%. The company's net income was $-143M, missing the average estimation of $-144M by -1.03%. Apple's SG&A was $46.55M, missing the average forecast of $73.54M by -36.70%. Lastly, the company's EPS was $-3.16, beating the average prediction of $-2.357 by 34.09%. In terms of the last quarterly report (Dec 2023), MeiraGTx's revenue was $2.04M, missing the average analysts' forecast of $6.56M by -68.91%. The company's EBITDA was $-43.754M, beating the average prediction of $-6.562M by 566.73%. MeiraGTx's net income was $20.22M, beating the average estimation of $1.79M by 1028.81%. The company's SG&A was $12.12M, missing the average forecast of $18.13M by -33.12%. Lastly, the company's EPS was $0.42, beating the average prediction of $0.025 by 1580.00%